Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
New investors in 2023 must understand the current market landscape. Familiarize yourself with essential tips and strategies to thrive in investing.
28,353 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
The idea of SpaceX buying Tesla sparks big questions for investors. This guide breaks down the chances, what it would...
Regulatory moves around AI can move crypto markets faster than a breakthrough in code. This piece explains what happe...
As Bausch Health prepares its Q4 2025 results, investors want clarity on margins, debt, and the pipeline. This guide ...
When a big fund buys in after a sharp drop, it sends a message about confidence and risk. This piece breaks down what...
SpaceX's IPO hype is hard to ignore, but there are four solid concerns investors should weigh before buying in. This ...
A bold policy move could reshape mortgage markets and investor returns. Here’s what’s behind Trump’s strategy, the po...
A rare two-step upgrade on Intel hints at a shifting AI investment narrative. This article breaks down what it means ...
In the first half of 2026, american superconductor corporation rallied as grid modernization and superconducting tech...
TJX delivered a solid quarter, lifting confidence in a consumer-driven recovery. This analysis dives into whether com...
Tech founder moves set a high bar for OpenAI's IPO. This article breaks down the reality behind altman called openai ...
A private-space pioneer with sprawling ambitions is stirring debate about valuation, growth, and risk. This guide bre...